Breaking Finance News

B. Riley reporeted on Nevro Corp (NASDAQ:NVRO), boosting its stock price target to $114.00 today

Indicating a possible upside of 0.20%, B. Riley raised the estimated target of Nevro Corp (NASDAQ:NVRO) to $114.

Only yesterday Nevro Corp (NASDAQ:NVRO) traded 2.77% higher at $94.93. NVRO’s 50-day average is $92.78 and its 200-day moving average is $73.58. The last stock price close is up 29.02% relative to the 200-day moving average, compared with the Standard & Poor’s 500 Index which has fallen -0.01% over the same period. Trading volume was was down over the average, with 363,625 shares of NVRO changing hands under the typical 500,070 shares..

See Graph Below:

Nevro Corp (NASDAQ:NVRO)

With a market cap of $0.0, Nevro Corp has a PE of 0 with a 52 week low of $36.51 and a one-year high of $100.83.

A total of 6 brokers have released a ratings update on the stock. One firm rate the stock a strong buy, five firms rate the stock a buy, 0 firms rate the stock a hold, 0 rate the stock to underperform, and lastly 0 analystsrate the company as sell with a one year target stock price of $80.67

Brief Synopsis About Nevro Corp (NASDAQ:NVRO)

Nevro Corp. is a medical device company. The Company has developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Company’s Senza system is a spinal cord stimulation (SCS) system that delivers its HF10 therapy. HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy offers back pain relief in addition to leg pain relief. HF10 therapy also provides pain relief without paresthesia. HF10 therapy offers benefits to patients, physicians and hospitals. The Company’s Senza is designed to create electrical impulses from 2 hertz to 10 kilohertz (kHz), including its HF10 therapy. HF10 therapy delivers waveforms at 10 kHz pulse rate with a statistically driven and clinically verified programming algorithm. Senza consists of leads, a trial stimulator, an implantable pulse generator (IPG), surgical tools, a clinician laptop programmer, and a patient remote control and a mobile charger.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.